MPAM
COLL icon

Monarch Partners Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Monarch Partners Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$4.16M Buy
179,129
+363
+0.2% +$7.32K 1.23% 19
2022
Q3 		$2.86M Buy
178,766
+23,465
+15% +$414K 0.86% 43
2022
Q2 		$2.75M Buy
155,301
+75,226
+94% +$1.27M 0.77% 54
2022
Q1 		$1.63M Hold
80,075
– – 0.36% 122
2021
Q4 		$1.5M Buy
80,075
+6,776
+9% +$132K 0.3% 137
2021
Q3 		$1.45M Buy
73,299
+7,104
+11% +$154K 0.21% 135
2021
Q2 		$1.56M Buy
66,195
+25,090
+61% +$580K 0.23% 129
2021
Q1 		$974K Sell
41,105
-1,215
-3% -$28.9K 0.15% 136
2020
Q4 		$848K Sell
42,320
-25,835
-38% -$504K 0.15% 152
2020
Q3 		$1.42M Buy
68,155
+21,970
+48% +$397K 0.32% 91
2020
Q2 		$808K Buy
46,185
+18,740
+68% +$367K 0.2% 108
2020
Q1 		$448K Buy
+27,445
New +$566K 0.16% 119
2019
Q2 		– Sell
-33,770
Closed -$511K – 171
2019
Q1 		$511K Hold
33,770
– – 0.08% 153
2018
Q4 		$580K Buy
33,770
+5,430
+19% +$92.9K 0.08% 141
2018
Q3 		$418K Buy
28,340
+6,000
+27% +$106K 0.04% 183
2018
Q2 		$533K Hold
22,340
– – 0.05% 173
2018
Q1 		$571K Buy
22,340
+8,060
+56% +$192K 0.05% 160
2017
Q4 		$264K Buy
+14,280
New +$205K 0.02% 181

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Monarch Partners Asset Management's COLL Position: Q4 2022 in Review

Monarch Partners Asset Management increased its Collegium Pharmaceutical (COLL) stake by 0.2% in Q4 2022, buying an estimated $7.32K and bringing the position to 179,129 shares worth $4.16M. The position accounts for 1.23% of the portfolio, ranked #19.

Monarch Partners Asset Management first reported a position in COLL in Q4 2017 and has held it in 18 quarters since. 179 funds tracked by Wall St. Rank hold COLL as of Q4 2022.

  • Monarch Partners Asset Management held 179,129 shares of Collegium Pharmaceutical worth $4.16M as of Q4 2022.
  • Monarch Partners Asset Management bought 363 Collegium Pharmaceutical shares in Q4 2022, an estimated $7.32K.
  • Collegium Pharmaceutical made up 1.23% of Monarch Partners Asset Management's portfolio in Q4 2022, its #19 holding.
  • Monarch Partners Asset Management first reported a position in Collegium Pharmaceutical in Q4 2017 and has held it in 18 quarters since.
  • 179 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2022.

Based on Monarch Partners Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.